Virtual Reality for Enhancement of Vision
Key facts
- Who runs it
- Stanford University
- Where
- Palo Alto, United StatesSee the site
- Trial code
- Status
- Terminated
- People taking part
- 22 people enrolled
- Started
- 17 Apr 2018
- Ended
- 7 Sept 2025
- Type of study
- Interventional, 2 groups
- Treatments tested
- Virtual Reality Stimulation
- Record updated
- 10 December 2025
- Why it stopped
- Due to Covid pandemic
Who can take part
- Age
- 12 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (14)Hide the full registry criteria
Who can take part
- For subjects with glaucoma, other retinal diseases, or disorders of the visual system:
- 1. Patient age > 12 years
- 2. Compliance with investigator instructions, tests and visit during subject participation in the study
- 3. Sufficient fixation ability
- 4.Best corrected visual acuity of 20/200 or better in at least one eye, or capable to see the visual stimulus at least in one eye; For healthy volunteers:
- 1. Patient age > 12 years
- 2. Compliance with investigator instructions, tests and visit during subject participation in the study
- 3.Best corrected visual acuity of 20/20 in both eyes
- 4. Sufficient fixation ability
Who cannot take part
- 2. Any metal artifacts in the head or truncus area (with the exception of dental implants)
- 1. Electric or electronic implants (such as cardiac pacemaker)
- 3. Epilepsy and photo-sensibility; acute auto-immune diseases
- 4. Acute conjunctivitis
- 5. Pathological nystagmus
Where in United States
- Byers Eye Institute at Stanford UniversityPalo Alto, United States
About the trial
What the trial wants to find out
This project aims to evaluate the use of Virtual Reality (VR) based visual stimulation for the treatment of blindness arising from Glaucoma and other retinal diseases or disorders of the visual system, through regeneration of axons of retinal ganglion cells (RGCs) in humans.
Read full original descriptionShow less
In certain cases of blindness, such as in Glaucoma, or in certain injuries, the optic nerves behind the retina of our eyes get damaged, leading to partial blindness, mostly near the periphery of our eye. Recent research in Dr.Huberman's laboratory has identified visual stimulation as a non-invasive model for regeneration of such damaged axons in rodents, back to the vision centers of their brain.
The 2 groups in the trial
- Virtual Reality Stimulation in Patients with Eye DisordersTreatment being tested
Participants use the VR headset for up to 1 year, followed by 1 year follow-up period.
Treatment: Virtual Reality Stimulation
- Virtual Reality Stimulation in Participants with Normal VisionTreatment being tested
Participants use the VR headset for up to 1 year, followed by 1 year follow-up period.
Treatment: Virtual Reality Stimulation
Results explained
A paper that names this trial, explained in plain words.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Record updated
- 10 December 2025